Skip to main content

Clinical Trials Using Mitomycin

Review the clinical trials studying mitomycin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-16 of 16

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Status: Active
Location: 241 locations
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Status: Active
Location: 129 locations
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Status: Active
Location: 4 locations
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients with Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Status: Active
Location: 3 locations
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Status: Active
Location: 2 locations
Transarterial Chemoembolization for the Treatment of Lung Cancer
Status: Active
Location: 2 locations
A Study Comparing Standard Treatments in People With Non-muscle Invasive Bladder Cancer (NMIBC), COMPARE IT Trial
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Stomach Cancer with Peritoneal Metastases
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Flat Dose or Weight-Based Dose of Mitomycin during Cytoreductive Surgery for the Treatment of Advanced Gastrointestinal Malignancy
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
HPV ctDNA Adapted Chemoradiation Therapy with or without Retifanlimab for the Treatment of Locally-Advanced Anal Cancer, CHART-AC Trial
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Combined Systemic and Intraperitoneal Chemotherapy for the Treatment of Gastric and/or Gastroesophageal Peritoneal Carcinomatosis
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
177Lu-PSMA-617 with Liver Directed Therapy for the Treatment of Castration Resistant Prostate Cancer with Liver Metastasis
Status: Active
Location: University of California San Francisco, San Francisco, California
Pressurized Intraperitoneal Aerosolized Chemotherapy with Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer with Peritoneal Metastases, The IMPACT Trial
Status: Approved
Location: 5 locations
Pressurized Intraperitoneal Aerosol Chemotherapy with Mitomycin C for the Treatment of Peritoneal Carcinomatosis from Gastrointestinal Cancers
Status: Approved
Location: Moffitt Cancer Center, Tampa, Florida
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland